Details of the Optogenetic System
| General Information of This Optogenetic System (OS) | ||||||
|---|---|---|---|---|---|---|
| OS ID |
OS00705
|
|||||
| OS Name |
Optogenetic controling ventromedial orbitofrontal cortex system 1
(Opto-vmOFC 1)
|
[1], [2] | ||||
|
Photoreceptor (PR) |
|
|||||
| Complementary Protein | Cryptochrome-interacting basic-helix-loop-helix 1 (CIB1/CIBN) | |||||
| Cofactor | Flavin adenine dinucleotide (FAD) | |||||
| Controlled Protein | Functional protein | Channelrhodopsin 2 | ||||
| OS Application Information (1) | ||||||
|---|---|---|---|---|---|---|
| Controlled Signal Pathway | Ventromedial orbitofrontal cortex system | |||||
| Effect | Activation | |||||
| Application | Cause mice behavior performance impairments | |||||
| Note | VmOFC is a potential therapeutic target for decision-making deficits in patients with schizophrenia | |||||
| Light Information | Activation Wavelength | 473 nm | ||||
| Deactivation Wavelength | Dark | |||||
| Light Intensity | 150-200 miliwatts | |||||
| Expression Information | Expression Method | Injection | ||||
| Cell Lines | Wistar rats vmOFC glutamate cells | |||||